DIMETHYL SULFOXIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Dimethyl Sulfoxide, and what generic alternatives are available?
Dimethyl Sulfoxide is a drug marketed by Mylan Institutional and Renova Pharms and is included in two NDAs.
The generic ingredient in DIMETHYL SULFOXIDE is dimethyl sulfoxide. Two suppliers are listed for this compound. Additional details are available on the dimethyl sulfoxide profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Dimethyl Sulfoxide
A generic version of DIMETHYL SULFOXIDE was approved as dimethyl sulfoxide by RENOVA PHARMS on July 7th, 2026.
US Patents and Regulatory Information for DIMETHYL SULFOXIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Institutional | DIMETHYL SULFOXIDE | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 076185-001 | Nov 29, 2002 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Renova Pharms | DIMETHYL SULFOXIDE | dimethyl sulfoxide | SOLUTION;INTRAVESICAL | 220173-001 | Jul 7, 2026 | AT | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
